ArticlePDF Available

Follow-up of HTLV-1 positive individuals in the GIPH cohort (1997-2013): Proviral load was not a prognostic marker for HAM/TSP

Authors:
  • Fundação Centro de Hematologia e Hemoterapia de Minas Gerais
  • Fundação Hemominas, Brazil, Belo Horizonte
POSTER PRESENTATION Open Access
Follow-up of HTLV-1 positive individuals in the
GIPH cohort (1997-2013): Proviral load was not a
prognostic marker for HAM/TSP
Poliane C Gonçalves
1
, Gabriela S Freitas
1,2*
, Luiz CF Romanelli
1
, Fernando A Proietti
1
, Anna B Carneiro-Proietti
1
,
Marina L Martins
1
From 16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada. 26-30 June 2013
Background
HTLV-1 proviral load (PVL) is considered a risk marker
for diseases.
Methods
Quantification of HTLV-1 PVL was performed in 151
samples of 38 asymptomatic carriers (AC) collected at
different times during follow-up (6.1 to 14.8 years, mean
10) and in samples of five individuals who developed
HAM/TSP during follow-up (2.6 to 11.3 years, mean 7.2).
We used SYBR Green and number of proviral copies/
10,000 cells. Fluctuation of proviral load level was defined
at 0.5 log or more.
Results
PVL was stable in 52.6% (20/38) and floated in 47.4%
(18/38) subjects. In AC, the median of PVL in the 1st sam-
ple was 85 and in the last 59 (p = 0.59). Among those indivi-
duals with low PVL who showed fluctuation, it remained
low (£1%) in 77.8%. In 60% with high PVL who showed
fluctuation, it remained high during follow-up. 10 patients
developed HAM/TSP during the follow-up, and PVL was
quantified before and after in 5 cases. Median of PVL in the
1st sample was 445, and in the last sample 98 (p = 0.56). In
all cases, PVL was higher in the asymptomatic period,
declining after onset of HAM/TSP.
Conclusions
PVL reaches a plateau, characteristic of each individual; high
PVL appears to be followed by decrease and stabilization in
lower levels. Although PVL is supposedly a risk marker for
HAM/TSP, it had modest prognostic value in our cohort;
changes in clinical status and PVL did not coincide, besides
occurrence of high stable PVL in AC. Hemominas/FAPE-
MIG/DECIT/MS.
Authorsdetails
1
GIPH (Interdisciplinary HTLV Research Group); Hemominas, Belo Horizonte,
Minas Gerais, Brazil.
2
Faculdade da Saúde e Ecologia Humana (FASEH),
Vespasiano, Minas Gerais, Brazil.
Published: 7 January 2014
doi:10.1186/1742-4690-11-S1-P23
Cite this article as: Gonçalves et al.: Follow-up of HTLV-1 positive
individuals in the GIPH cohort (1997-2013): Proviral load was not a
prognostic marker for HAM/TSP. Retrovirology 2014 11(Suppl 1):P23.
Submit your next manuscript to BioMed Central
and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
* Correspondence: gabrielaaseabra@gmail.com
1
GIPH (Interdisciplinary HTLV Research Group); Hemominas, Belo Horizonte,
Minas Gerais, Brazil
Full list of author information is available at the end of the article
Gonçalves et al.Retrovirology 2014, 11(Suppl 1):P23
http://www.retrovirology.com/content/11/S1/P23
© 2014 Gonçalves et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attri bution License (http://c reativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproductio n in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made availab le in this article, unless other wise stated.
... However, in a long-term study presented by Goncalves et al., PVL only had modest prognostic value in the examined GIPH cohort. Moreover, changes in clinical status and PVL did not coincide in this study: for all five patients for whom PVL was determined both prior to and after development of disease, the median PVL was dramatically higher during the asymptomatic period than after the onset of HAM/ TSP [191]. ...
Article
Full-text available
The 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses was held in Montreal, Quebec from June 26th to June 30th, 2013 and was therefore hosted by a Canadian city for the first time. The major topic of the meeting was human T-lymphotropic viruses (HTLVs) and was covered through distinct oral and poster presentation sessions: clinical research, animal models, immunology, molecular and cellular biology, human endogenous and emerging exogenous retroviruses and virology. In this review, highlights of the meeting are provided by different experts for each of these research areas.
ResearchGate has not been able to resolve any references for this publication.